Meta-analyses involving cross-over trials: Methodological issues

International Journal of Epidemiology

Volumn 40, Issue 6, 2011, Pages 1732-1734

  Stedman, Margaret R ^a   Curtin, François ^b   Elbourne, Diana R ^c   Kesselheim, Aaron S ^a,d   Brookhart, M Alan ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MERCK SERONO S A   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; HUMAN; LETTER; MANTEL HAENSZEL TEST; META ANALYSIS (TOPIC); METHODOLOGY; PARALLEL DESIGN; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; SEIZURE;

CROSS-OVER STUDIES; HUMANS; META-ANALYSIS AS TOPIC;

EID: 83455165121     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp345     Document Type: Letter

References (6)

1. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV. Meta-analysis involving cross-over trials: methodological issues. Int J Epidemiol 2002;31: 140-49.
2. Becker MP, Balagtas CC. Marginal modeling of cross-over data. Biometrics 1993;49:997-1009.
3. Curtin F, Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over trials. II: binary outcomes. Stat Med 2002;21:2145-59.
4. Kishore K, Jailakhani BL, Sharma JN, Ahuja GK. Serum phenytoin levels with different brands. Indian J Physiol Pharmacol 1986;30:171-76.
5. Oles KS, Penry JK, Smith LD, Anderson RL, Dean JC, Riela AR. Therapeutic bioequivalency study of brand name versus generic carbamazepine. Neurology 1992;42:1147-53.
6. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. San Diego: Academic Press Inc., 1985.